Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

Feldman, Steven

One or more keywords matched the following items that are connected to Feldman, Steven

Item Type	Name
Academic Article	The safety of liposuction: results of a national survey.
Academic Article	Etanercept improves the health-related quality of life of patients with psoriasis: results of a phase III randomized clinical trial.
Academic Article	Cost-effectiveness of biologic treatments for psoriasis based on subjective and objective efficacy measures assessed over a 12-week treatment period.
Academic Article	A pharmacoeconomic analysis of severe psoriasis therapy: a review of treatment choices and cost efficiency.
Academic Article	Efficacy and safety of calcipotriene 0.005% foam for the treatment of plaque-type psoriasis: results of two multicenter, randomized, double-blind, vehicle-controlled, phase III clinical trials.
Academic Article	Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial.
Academic Article	Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: results from a randomized, controlled Phase III study.
Academic Article	Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial.
Academic Article	Long-term safety of ketoconazole foam, 2% in the treatment of seborrheic dermatitis: results of a phase IV, open-label study.
Concept	Postoperative Period
Concept	Clinical Trials, Phase II as Topic
Concept	Clinical Trials, Phase III as Topic
Academic Article	Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study.
Academic Article	Tofacitinib improves pruritus and health-related quality of life up to 52 weeks: Results from 2 randomized phase III trials in patients with moderate to severe plaque psoriasis.
Academic Article	Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial.
Academic Article	Treating Moderate-to-Severe Plaque Psoriasis With Guselkumab: A Review of Phase II and Phase III Trials.
Academic Article	Higher Psoriasis Skin Clearance Is Associated with Lower Annual Indirect Costs in the United States: A Post Hoc Analysis from the CLEAR Study.
Academic Article	Cost Per Additional Responder Associated With Ixekizumab and Etanercept in the Treatment of Moderate-to-Severe Psoriasis.
Academic Article	Investigational drugs in phase II clinical trials for moderate to severe plaque psoriasis - potential new treatments on the horizon.
Academic Article	Tildrakizumab: A Review of Phase II and III Clinical Trials.
Academic Article	Correlation Between Change in Psoriasis Area and Severity Index and Dermatology Life Quality Index in Patients with Psoriasis: Pooled Analysis from Four Phase 3 Clinical Trials of Secukinumab.

Search Criteria

S Phase